Zhang Feng-min, Yang Bao-feng, Gu Hong-xi, Chen Xiao-bei, Zhong Zhao-hua, Cheng Zhi
Department of Microbiology, Harbin Medical University, Harbin 150086, China.
Acta Pharmacol Sin. 2004 Feb;25(2):208-12.
To investigate the effect of tacrolimus (FK506) on the infection of Friend murine leukemia virus (Friend MuLV) in vivo.
Three kinds of mice were used including Friend MuLV-sensitive BALB/c mice, Friend MuLV-resistant Fv-4 gene-homozygous mice (Fv-4 mice), and Friend MuLV-resistant Fv-4 gene-heterozygous mice (F1 mice). Tacrolimus was administrated i.p. to those mice in every 2 d. Those treated mice were inoculated i.p. with Friend MuLV once on d 3. The symptoms and viral proliferations in those mice were observed to recognize the Friend MuLV infection. The expression and genotype of Fv-4 gene that resistant against the infection of Friend MuLV were analyzed to confirm the genomic background and related mechanism of the resistance.
BALB/c mice and F1 mice, but not Fv-4 mice, appeared obvious early death, spleenomegaly, and viral proliferation after both treatments of viral inoculation and tacrolimus administration, whereas the expression and genotype of Fv-4 gene was not changed in F1 mice and Fv-4 mice with treatment of tacrolimus. Compared to the virus-inoculated control, the Friend MuLV-sensitivity of tacrolimus-treated BALB/c mice and the Friend MuLV-resistance of tacrolimus-treated Fv-4 mice were the same as the controls, but only F1 mice became the symptoms and viral proliferation after both treatments. It suggested the Friend MuLV-resistant F1 mice could be converted to be Friend MuLV-sensitive by treatment of tacrolimus, and this conversion was not depended on the expression and genotype of Fv-4 gene.
Tacrolimus could not inhibit the infection of Friend MuLV in all mice, furthermore, it could enhance the infection of Friend MuLV in F1 mice. The enhancement may be related to the immunosuppressive effect of tacrolimus.
研究他克莫司(FK506)对体内Friend小鼠白血病病毒(Friend MuLV)感染的影响。
使用三种小鼠,包括对Friend MuLV敏感的BALB/c小鼠、对Friend MuLV耐药的Fv-4基因纯合小鼠(Fv-4小鼠)和对Friend MuLV耐药的Fv-4基因杂合小鼠(F1小鼠)。每2天给这些小鼠腹腔注射他克莫司。在第3天,给这些处理过的小鼠腹腔注射一次Friend MuLV。观察这些小鼠的症状和病毒增殖情况以识别Friend MuLV感染。分析对Friend MuLV感染具有抗性的Fv-4基因的表达和基因型,以确认抗性的基因组背景和相关机制。
在病毒接种和他克莫司给药这两种处理后,BALB/c小鼠和F1小鼠出现明显的早期死亡、脾肿大和病毒增殖,但Fv-4小鼠未出现;而在接受他克莫司治疗的F1小鼠和Fv-4小鼠中,Fv-4基因的表达和基因型未发生变化。与病毒接种对照组相比,他克莫司处理的BALB/c小鼠对Friend MuLV的敏感性以及他克莫司处理的Fv-4小鼠对Friend MuLV的抗性与对照组相同,但只有F1小鼠在两种处理后出现症状和病毒增殖。这表明,用他克莫司处理可使对Friend MuLV具有抗性的F1小鼠转变为对Friend MuLV敏感,且这种转变不依赖于Fv-4基因的表达和基因型。
他克莫司不能抑制所有小鼠体内Friend MuLV的感染,此外,它还可增强F1小鼠体内Friend MuLV的感染。这种增强可能与他克莫司的免疫抑制作用有关。